Interplay of the 3D genome and epigenome in androgen-driven prostate cancer
Elyssa M. Campbell, Dayna Challis, Susan J. Clark, Joanna Achinger-Kawecka · 2026
Read Interplay of the 3D genome and epigenome in androgen-driven prostate cancer by Elyssa M. Campbell, Dayna Challis, Susan J. Clark, Joanna Achinger-Kawecka (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13313260.txt.
Description
Elyssa M Campbell and co-authors offer a 2026 perspective on prostate cancer. They argue that the 3D folding of the genome is the missing layer in understanding treatment resistance. The androgen receptor drives these tumors, and drugs blocking it work until cancers rewire themselves. The rewiring plays out not just in chemical marks on DNA. It also plays out in how chromatin loops and folds, bringing distant enhancers into contact with genes and reshuffling transcription factor networks.
Standard epigenetic thinking, focused on linear marks, misses those spatial conversations. Drawing on recent biology and new measurement technology, the authors propose a framework built around patient-specific 3D vulnerabilities. The idea is to map how a tumor's chromatin is folded. Therapies can then attack its topology and collapse the gene programs keeping the cancer alive. The piece is a call to widen epigenetic drug development beyond flat maps of the genome.
Catalog record
| CREATOR | Elyssa M. Campbell, Dayna Challis, Susan J. Clark, Joanna Achinger-Kawecka |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |